Takayuki Shimamoto

Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review

K. Takayama, J. Uchino, Tadaaki Yamada, 2020, Journal of clinical medicine.

Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer.

K. Takayama, J. Uchino, M. Inoue, 2019, Lung cancer.

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients

K. Takayama, J. Uchino, Tadaaki Yamada, 2020, Scientific Reports.

Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

K. Takayama, J. Uchino, Tadaaki Yamada, 2019, Journal of clinical medicine.

The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer.

K. Takayama, J. Uchino, Tadaaki Yamada, 2019, Translational lung cancer research.

Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis.

C. Sotozono, K. Takayama, J. Uchino, 2020, Allergology international : official journal of the Japanese Society of Allergology.

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)

K. Takayama, J. Uchino, F. Kiyomi, 2020, Therapeutic advances in medical oncology.

Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping Mutation

Nozomi Tani, Yoshie Morimoto, Takayuki Shimamoto, 2023, Cureus.